Postremission therapy

From WikiMD's Wellness Encyclopedia

Postremission therapy, sometimes referred to as consolidation therapy, is a phase of cancer treatment that occurs after the initial therapy has successfully brought about a remission of the disease. It is designed to kill any remaining cancer cells in the body and prevent a relapse.

Background[edit | edit source]

While the initial treatment phase, commonly known as induction therapy, aims to achieve remission by reducing the signs and symptoms of the disease, there may still be a small number of cancer cells present. Postremission therapy is crucial to ensure these residual cells are eradicated, reducing the risk of relapse.

Rationale[edit | edit source]

The need for postremission therapy arises from the understanding that:

  • Microscopic amounts of disease, undetectable by conventional methods, can still lead to relapse.
  • The body's natural defenses, even aided by the initial therapy, might not be sufficient to eradicate all remaining cancer cells.

Types of Postremission Therapy[edit | edit source]

The specific type of therapy recommended can vary depending on the type of cancer, the patient's overall health, and other factors:

  • Chemotherapy: Powerful drugs are used to kill cancer cells or prevent them from dividing.
  • Radiation therapy: High-energy x-rays or other types of radiation are employed to destroy cancer cells.
  • Stem cell transplant: Replaces the blood-forming cells in the bone marrow that have been killed by chemotherapy and/or radiation therapy.
  • Targeted therapy: Uses drugs or other agents to identify and attack specific cancer cells without harming normal cells.
  • Immunotherapy: Boosts the body's natural defenses to fight cancer.

Indications[edit | edit source]

Postremission therapy is commonly indicated for:

  • Acute leukemias: Especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
  • Certain aggressive Lymphomas.
  • Some solid tumors, depending on their risk of recurrence.

Considerations[edit | edit source]

There are several factors healthcare providers consider when prescribing postremission therapy:

  • Type and Stage of Cancer: More aggressive cancers might require intensive therapy.
  • Age and Overall Health: Older patients or those with significant co-morbidities might receive less aggressive treatment.
  • Response to Induction Therapy: The patient's response to initial treatment can influence the choice and intensity of postremission therapy.

Side Effects[edit | edit source]

Postremission therapies, like other cancer treatments, can have side effects:

  • Fatigue
  • Nausea and vomiting
  • Increased susceptibility to infections
  • Hair loss
  • Mouth sores
  • Changes in appetite
  • Skin reactions (for radiation therapy)


Postremission therapy Resources

Contributors: Prab R. Tumpati, MD